HALOZYME THERAPEUTICS INC's ticker is HALO and the CUSIP is 40637H109. A total of 210 filers reported holding HALOZYME THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.39 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,866 | -100.0% | 101,211 | -62.7% | 0.01% | -68.8% |
| Q3 2022 | $10,740,000 | +53.3% | 271,615 | +70.6% | 0.02% | +60.0% |
| Q2 2022 | $7,005,000 | -58.6% | 159,201 | -61.7% | 0.01% | -52.4% |
| Q3 2021 | $16,929,000 | +916.1% | 416,140 | +556.4% | 0.02% | +600.0% |
| Q3 2020 | $1,666,000 | +397.3% | 63,400 | +407.9% | 0.00% | +200.0% |
| Q2 2020 | $335,000 | -82.1% | 12,484 | -88.0% | 0.00% | -80.0% |
| Q1 2020 | $1,873,000 | -72.6% | 104,097 | -73.0% | 0.01% | -68.8% |
| Q4 2019 | $6,848,000 | +305.7% | 386,241 | +254.9% | 0.02% | +300.0% |
| Q3 2019 | $1,688,000 | +61.2% | 108,846 | +67.3% | 0.00% | +100.0% |
| Q1 2019 | $1,047,000 | -88.9% | 65,055 | -86.5% | 0.00% | -90.9% |
| Q1 2018 | $9,437,000 | +7103.8% | 481,718 | +4622.7% | 0.02% | – |
| Q2 2017 | $131,000 | – | 10,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SNYDER CAPITAL MANAGEMENT L P | 4,324,232 | $165,185,662 | 3.73% |
| Steamboat Capital Partners, LLC | 196,898 | $7,521,504 | 2.79% |
| 2Xideas AG | 600,799 | $22,950,522 | 2.54% |
| BERNZOTT CAPITAL ADVISORS | 171,808 | $6,563,066 | 2.26% |
| Redwood Investments, LLC | 328,459 | $12,547,134 | 1.70% |
| Mesirow Institutional Investment Management, Inc. | 380,415 | $14,531,853 | 1.47% |
| Granite Investment Partners, LLC | 856,253 | $32,708,865 | 1.37% |
| Penn Capital Management Company, LLC | 324,707 | $12,453,211 | 1.28% |
| EFG Asset Management (North America) Corp. | 137,739 | $5,262,319 | 1.25% |
| First Light Asset Management, LLC | 313,536 | $11,977,075 | 1.14% |